Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Alibaba Health Information Technology EV-to-EBIT?
Alibaba Health Information TechnologyALBHF 51 EV-to-EBIT is 17.72 as of Aug. 07, 2026, which is 30% below its 10-year median of 25.46. GuruFocus rates ALBHF with a GF Score™ of 51/100 and a GF Value™ of $0.66 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 471 Healthcare Providers & Services companies, Alibaba Health Information Technology ranks worse than 60.3% on this metric.
ALBHF'
s EV-to-EBIT Range Over the Past 10 Years
Min: -4585.12 Med: 25.46 Max: 10114.68
Current: 17.82
During the past 13 years, the highest EV-to-EBIT of Alibaba Health Information Technology was 10114.68. The lowest was -4585.12. And the median was 25.46.
ALBHF's EV-to-EBIT is ranked worse than 60.3% of 471
companies
in the Healthcare Providers & Services industry
Industry Median: 16.04
vs ALBHF: 17.82
Alibaba Health Information Technology (OTCPK:ALBHF) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Alibaba Health Information Technology's Enterprise Value for the quarter that ended in Mar. 2026 was $8,342 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Alibaba Health Information Technology's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $323 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology EV-to-EBIT Related Terms
Alibaba Health Information Technology EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology EV-to-EBIT Chart
Alibaba Health Information Technology EV-to-EBIT Competitor Comparison
For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alibaba Health Information Technology EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Alibaba Health Information Technology's EV-to-EBIT falls into.
Alibaba Health Information Technology's current Enterprise Value is $5,731 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Alibaba Health Information Technology's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $323 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology (ALBHF) has a EV-to-EBIT of 17.72 as of Aug. 07, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Alibaba Health Information Technology and its competitors. This is 30% below median its historical median of 25.46. According to the industry distribution chart, Alibaba Health Information Technology ranks #284 out of 471 companies in the Healthcare Providers & Services industry, placing it in the top 60.3%.
Is Alibaba Health Information Technology's EV-to-EBIT too high?
Alibaba Health Information Technology's current EV-to-EBIT of 17.72 is 30% below median its 10-year median of 25.46. The Healthcare Providers & Services industry median EV-to-EBIT is 16.04. Alibaba Health Information Technology's value of 17.72 is 10.5% above this industry median. Based on the distribution chart, Alibaba Health Information Technology ranks #284 out of 471 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Alibaba Health Information Technology has a GF Score™ of 51/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's EV-to-EBIT compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Alibaba Health Information Technology ranks #284 out of 471 companies for EV-to-EBIT. This places Alibaba Health Information Technology in the lower half of its industry. The industry median EV-to-EBIT is 16.04. Alibaba Health Information Technology's value of 17.72 is 10.5% above this benchmark. While the company's 10-year median is 25.46 vs. the industry median of 16.04, Alibaba Health Information Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 16.04, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alibaba Health Information Technology's current EV-to-EBIT of 17.72 is 10.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Alibaba Health Information Technology and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 16.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alibaba Health Information Technology's current EV-to-EBIT is 17.72, which is 30% below median its own 10-year median of 25.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBHF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.66, compared to a current price of $0.45 — trading 32.5% below its estimated fair value. The current EV-to-EBIT is 17.72, which is 30% below median its 10-year median of 25.46 and 10.5% above the Healthcare Providers & Services industry median of 16.04. Alibaba Health Information Technology's overall GF Score™ is 51/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBHF), the current EV-to-EBIT is 17.72 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alibaba Health Information Technology (ALBHF) Overvalued in 2026?
Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued.
The current stock price of $0.45 is trading 32.5% below its estimated GF Value™ of $0.66.
GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.
Key valuation signals for ALBHF:
EV-to-EBIT: 17.72 (30% below median its 10-year median of 25.46)
GF Value™: $0.66 vs. price of $0.45 (32.5% below fair value)
Industry Position: 10.5% above the Healthcare Providers & Services median (#284 of 471)
No single metric tells the full story. See the ALBHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
51GF Score
Get the complete analysis for ALBHF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALBHF has been successfully added to your 
